Tarsus Pharmaceuticals, Inc.TARSNASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank86
3Y CAGR+120.4%
5Y CAGR+107.2%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+120.4%/yr
vs +109.5%/yr prior
5Y CAGR
+107.2%/yr
Recent acceleration
Acceleration
+10.9pp
Accelerating
Percentile
P86
Within normal range
vs 5Y Ago
38.2x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $6.61M | +31.8% |
| 2024 | $5.01M | -31.0% |
| 2023 | $7.26M | +1077.5% |
| 2022 | $617000.00 | +138.2% |
| 2021 | $-1.61M | -1033.5% |
| 2020 | $173000.00 | +146.6% |
| 2019 | $-371000.00 | -1259.4% |
| 2018 | $32000.00 | - |